NextConsensus
Discuss a Program
Available now · In validation · Research program

Claim Intelligence is available as a scoped program. The other two tiers still have to earn their place.

Claim Intelligence is the one available to contract now. Claim-trajectory reconstruction against a scope agreed in writing, delivered with the revision history behind every finding. The other two tiers are labelled for where they actually stand.

What you bring

  • One claim, drug, or class where knowing what moved would change your priorities. Starting with one keeps the first question bounded and tells you whether a broader review is worth pursuing.
  • The decision it feeds: evidence strategy, market access plan, or claim review.
  • A willingness to act on the answer, including "not yet consequential."

Available now

Claim Intelligence

How claims about your drugs, your competitors, or a whole area emerged, changed, and spread, read out of the dated revisions of FDA and EMA label text, guideline entries from bodies such as NCCN, published coverage policies, and the trial literature behind them.

  • Trajectory reconstruction. First appearance through wording changes, evidence, persistence, spread. Every step carries the revision date and the source document it came from.
  • Historical provenance. When it emerged, whether contested, how long it held.
  • Source-by-source comparison. The same claim diffed across the drug page, the condition page and the class review, so you can see where the wording already diverges.
  • Cohort analysis. Which claims are shared, contested, or unique to one drug.
  • Named-scope reconstruction. Claims you identify, with a dated record of the public changes captured.

Rebuilt from dated public revisions, each one carrying a SHA-256 hash you can recompute in your browser against the same sources. Nothing in a reconstruction is unsourced.

In validation

Trajectory Prioritization

Prioritization, not just reconstruction. The review workflow is being evaluated before it is offered as a separate product.

  • Trajectory prioritization. Organizes evidence movement into a review queue.
  • Evidence context. Shows the public record and its limits alongside each item.
  • Prioritization workflow. Evaluated before it is made contractable.

Not contractable yet. When it ships it is scoped as a paid extension of a Claim Intelligence program.

Research program

Forecasting

Researches whether public evidence states support forecasts of defined rung 5–7 transitions: a guideline body changing a recommendation, a regulator changing a label, a payer changing coverage. Tracked via the Verification Ledger.

  • Registered authority forecasts. Prospectively registered, immutable, independently adjudicated.
  • Evaluation record. Published after a sufficient number of records resolve.
  • Timing analysis. Reported with the quality and alert burden needed to interpret it.

Available as a research collaboration. The public record will show what the forecasts establish and what they do not.

Clear boundaries between programs

Each program is judged on its own evidence and evaluation standard. Historical reconstruction is reproducible from public sources; forecasting is reported only when its registered records can support an interpretable result.

Questions involving safety or adverse events require a separate review of the applicable evidence and scope.

For the person who has to vouch for it

The two parts that decide whether the output is trustworthy.

Change-type classification

Every event is labelled: evidence movement, public assimilation, authority-language importation, editorial maintenance, or noise. Without it, housekeeping and a claim gaining ground look alike.

Provenance hashes

Byte-for-byte reproducible from the public record; the hash proves it has not been altered.

Operational leverage

From scattered revisions to a living system of record.

Manual review means tracking disparate documents and hoping not to miss a shifted restriction or emerging subgroup signal. A program compiles that history into a single time-indexed, source-linked asset that can be re-reviewed on demand.

Dimension
Manual Workflow Manual Dossier Review
NextConsensus Dated Trajectory Reconstruction
Source coverage
Fragmented public records

Reviewers move between version histories, supporting documents, and authority pages.

Dated revision reconstruction

Builds a source-linked trajectory from the public revision history available for the program.

Qualifier & limitation tracking
Missed wording changes

Subtle qualifier changes are easy to lose when versions are reviewed separately.

Word-level comparison

Shows added, removed, or restored qualifiers with source-anchored timestamps.

Cross-surface comparison
Disconnected reads

Evidence, wording, and authority context often sit in separate documents.

One trajectory record

Keeps captured evidence, wording changes, and source spread in the same dated record.

Re-running a review
Manual reassembly

A changed source can force another pass through the same history.

Reproducible reruns

The same captured history can be rerun and compared against the earlier record.

Auditability & provenance
Unanchored summaries

A summary is difficult to check when its source versions and dates are not kept with it.

Hashable source record

Each published reconstruction carries source references and a reproducibility marker.

Boundary

What we produce, and what you decide

We reconstruct the trajectories, classify the movement, and hand over the evidence. Whether one is material, and what to do about it, is yours.

How a program starts

Nothing is signed until both scope and figure are in writing.

  1. First conversation

    Send the drug, class, or area and the decision it feeds. Start with public sources and high-level context.

  2. Fit decision, including no

    Whether the public record there is thick enough to reconstruct from. If it is not, you get that answer in writing instead of a proposal.

  3. Fixed-scope statement of work

    Which drugs, how far back, how many claims monitored, what you receive and when, with the figure attached.

  4. Contracting and delivery

    Any confidentiality, data-processing, retention, and delivery terms are settled in writing before work starts.

On price. No list price, because there is no standard scope. Four things move the figure, and the statement of work fixes all four: how many drugs or claims are covered, how far back the reconstruction goes, whether the record is monitored afterwards or delivered once, and how much of the source trail is assembled rather than linked. Scope and figure arrive together, in writing, before any commitment.

Validation status by forecast class

Forecasting is offered as structured judgment; no class has a resolved calibration record yet.